247 related articles for article (PubMed ID: 19874423)
1. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.
Son MY; Kim MJ; Yu K; Koo DB; Cho YS
J Cell Mol Med; 2011 Jan; 15(1):152-65. PubMed ID: 19874423
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
Ruscica M; Dozio E; Boghossian S; Bovo G; Martos Riaño V; Motta M; Magni P
Endocrinology; 2006 Mar; 147(3):1466-73. PubMed ID: 16339211
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
6. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
Lecat S; Belemnaba L; Galzi JL; Bucher B
Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells.
Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):944-50. PubMed ID: 15293057
[TBL] [Abstract][Full Text] [Related]
10. Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.
Pons J; Kitlinska J; Jacques D; Perreault C; Nader M; Everhart L; Zhang Y; Zukowska Z
Can J Physiol Pharmacol; 2008 Jul; 86(7):438-48. PubMed ID: 18641693
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
14. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
[TBL] [Abstract][Full Text] [Related]
15. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection.
Santos-Carvalho A; Álvaro AR; Martins J; Ambrósio AF; Cavadas C
Prog Neurobiol; 2014 Jan; 112():70-9. PubMed ID: 24184719
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
[TBL] [Abstract][Full Text] [Related]
19. NPY stimulates cholesterol synthesis acutely by activating the SREBP2-HMGCR pathway through the Y1 and Y5 receptors in murine hepatocytes.
Chen F; Zhou Y; Yang K; Shen M; Wang Y
Life Sci; 2020 Dec; 262():118478. PubMed ID: 32976883
[TBL] [Abstract][Full Text] [Related]
20. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB.
Sheriff S; Dayal R; Kasckow J; Regmi A; Chance W; Fischer J; Balasubramaniam A
Regul Pept; 1998 Sep; 75-76():309-18. PubMed ID: 9802424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]